Croda Denmark

Denmark

Croda Denmark was formerly Brenntag Biosector (Biosector), acquired in 2019 and for more than 80 years has been dedicated to safe and effective adjuvants for use in human and veterinary vaccines. No other company can match our expertise in this area.

Our site at Frederikssund includes R&D, engineering, production QA/QC, administration, warehouse and distribution: 

  • World leading adjuvant specialist serving major human and veterinary vaccine producers
  • Industry leading R&D capabilities for a strong pipeline of innovative next generation vaccine adjuvants
  • Running the only aseptic and GMP certified manufacturing site for adjuvants globally

The combination of a passionate team, adjuvant expertise, industry-leading production facilities and a dedicated global sales network committed to understanding customer needs mean we can better serve our pharmaceutical customers through our classic portfolio and our rich development pipeline. We realise the vaccines and blood products of tomorrow require new and innovative adjuvants, so our R&D department is focused on the next generation of adjuvants.

Croda Denmark

Elsenbakken 23
3600 Frederikssund
Denmark

Further reading

BMAC

Croda crowned Britain’s Most Admired Chemicals Company for eighth year running

15 January 2025: the company that uses smart science to create high-performance ingredients and solutions that improve lives, has been voted Britain’s Most Admired Chemicals Company for the eighth...
Our brand evolution

Croda announces brand evolution to mark centenary year

6 January 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, today announces a brand evolution to...
Ian Bull

Directorate change

John Ramsay, having served as a non-executive director and Chair of Audit Committee for over 5 years, will retire from the Board on 1 March 2025 and will be replaced by Ian Bull.